FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
Track all the latest updates and news of HPC Biosciences IPO.
June 5, 2020 3:30:00 AM
IPOs On TheStreet Opinion: NEUTRAL - Read Avidity Biosciences, (RNA), Biopharma, IPOs On TheStreet Opinion: NEUTRAL - Read The AZEK Company, (AZEK), Consumer, IPOs On TheStreet Opinion ...
Published by : TheStreet.comFebruary 20, 2024 11:26:00 AM
We built our IPO process in partnership with the investment banking community, ensuring that they have the control and information they need to successfully open your IPO. Nasdaq�s best-in-class ...
Published by : NasdaqMarch 1, 2023 6:36:00 PM
Reported Earlier, IB Acquisition Prices $100M Initial Public Offering of 10M Units At $10/Unit Reddit IPO Potential 'Watershed' Moment For Tech Industry, Says Wedbush's Dan Ives: Expects It To Hit ...
Published by : Benzinga.comJanuary 24, 2024 4:00:00 PM
The new Nasdaq IPO Pulse Index functions as a leading indicator for the IPO Market by forecasting the direction of US IPO activity over the next six months. IPO activity rises and falls in cycles.
Published by : NasdaqFebruary 27, 2024 11:27:00 PM
Now, Reddit itself is hoping to tap into its users� unruly energy by allowing them to participate in the company�s IPO. Reddit filed to go public last Thursday, seeking a valuation of at least ...
Published by : TimeMarch 12, 2024 3:30:00 AM
Reddit (RDDT) is set to go public soon and is as of now, one of the most highly anticipated initial public offerings (IPOs) of 2024. The social media company, led by CEO Steve Huffman, is seeking ...
Published by : MashableAugust 11, 2023 7:46:00 PM
The market for initial public offerings (IPO) is starting to heat up after a period of calm, which might have some folks wondering "what is an IPO?" An initial public offering enables a private ...
Published by : KiplingerMarch 14, 2024 3:31:00 AM
Jami Taylor; VP of IR; Coherus BioSciences, Inc. Dennis Lanfear; President and CEO; Coherus BioSciences, Inc. Paul Reider; Chief Commercial Officer; Coherus ...
Published by : Yahoo FinanceMarch 25, 2024 3:30:00 AM
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings ...
Published by : MorningstarMarch 5, 2024 8:58:00 PM
Avidity Biosciences stock has gained more than 20% ... The company's market cap valuation is approximately $1.5 billion. Its IPO raised $259 million in June 2020 at $18 per share.
Published by : Seeking AlphaMarch 26, 2024 3:30:00 AM
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...
Published by : Wall Street JournalFebruary 28, 2024 3:44:00 PM
LONDON, Feb 28 (Reuters Breakingviews) - Klarna�s investors have reason to hanker after an initial public offering now. The Swedish buy now, pay later (BNPL) firm on Wednesday, opens new tab ...
Published by : ReutersHPC Biosciences IPO to list on Tuesday, March 19, 2013. IPO of HPC Biosciences was open on Mar 01, 2013 and closed on Mar 05, 2013.
HPC Biosciences IPO Listing Date
Listing Date: Tuesday, March 19, 2013
BSE Scrip Code: 535217
Listing In: ‘MT’ Group of Securities
ISIN: INE507O01017
Issue Price: Rs. 35.00 Per Equity Share
Face Value: Rs. 10.00 Per Equity Share
HPC Biosciences Ltd is entering in the capital markets (through BSE SME) with an initial public offering, IPO of 4,500,000 Equity Shares of Rs 10/- each aggregating upto Rs 15.75 crore. The price for the issue has been fixed at Rs 35/- per share.
HPC Biosciences Ltd is engaged in the business of agriculture industry which includes cultivation, processing and distribution of agriculture commodities like wheat, paddy, sugar cane, fruits, vegetables and flowers. Also they are planting Bamboos, Kadam, Poplar, Eucalyptus and Kadam.
The issue opens on Mar 01, 2013 and closes for subscription on Mar 05, 2013. The equity shares of the issue are proposed to be listed on the SME Platform of BSE Limited.
The HPC Biosciences IPO is proposed to open on March 1, 2013. The IPO application ends on March 5, 2013.
Retail investors can apply in the retail or non-institutional investor category from March 1, 2013 to March 5, 2013. The HPC Biosciences IPO can be applied online through Net Bank (ASBA method) or the stock broker (UPI method).
The HPC Biosciences IPO will open for subscription on March 1, 2013. The public issue will close on March 5, 2013.
Useful Articles
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|